South African GASTROENTEROLOGY Review | Volume 17 Issue 3 2019

THE SOUTH AFRICAN GASTROENTEROLOGY REVIEW 2019 | ISSUE 3 | 4 S4 Mitogut 40. Each vial contains esomeprazole sodium equivalent to esomeprazole 40 mg. Reg. No.: 47/11.4.3/0800 Dr. Reddy’s Laboratories (Pty) Ltd. Reg no. 2002/014163/07. Third Floor, The Place, 1 Sandton Drive, Sandton 2196, South Africa. Tel: +27 11 324 2100, Fax: +27 11 388 1262 , www.drreddys.co.za . ZA/06/2018-20/MITOGUT/109. Mitogut 40 I.V. MITOGUT 40 is indicated for: 1 • Gastro-oesophageal Reflux Disease as an alternative where oral therapy is not appropriate and for the shortest possible time. > Gastro-oesophageal Reflux Disease: - Treatment of erosive reflux oesophagitis - Long-term management of patients with healed oesophagitis to prevent relapse - Treatment of severe symptoms of reflux disease • Short-term maintenance of haemostasis and prevention of rebleeding in patients following therapeutic endoscopy for acute bleeding gastric or duodenal ulcers. Dr. Reddy’s References: 1. Mitogut 40 Package Insert. For full prescribing information refer to the package insert approved by the medicines regulatory authority.